Recent articles

During a recent Breakthrough T1D Facebook Live event, Mary Beth McNerney of Xeris Pharmaceuticals and Christine Beebe, MS, RD and Diabetes Educator discussed a new way to take charge of severe hypoglycemia episodes (“severe hypos”).  

Breakthrough T1D is making the following commitments internally and to the T1D community to deliver tangible results for Black Americans living with T1D.

At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the most important topics, from artificial pancreas trials to immune therapy trials to prevention trials, all with the same goal: ending type 1 diabetes (T1D) and improving lives until that day comes. Breakthrough T1D played the […]

The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics, from beta cell replacement to regeneration and glucose and complications trials, all with the result to change things for the type 1 diabetes (T1D) community. Here are Drs. Emily Sims, Jay Skyler, Marian Rewers and […]

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the latest in T1D news updates

Sign up for Insider News to receive breaking news updates from Breakthrough T1D.

  • This field is for validation purposes and should be left unchanged.